Skip to main content

Effect of Drug Therapy on the Metabolism of Phenytoin

  • Conference paper

Abstract

It is common clinical experience that phenytoin is an unpredictable drug to use in practice. Some patients can tolerate doses of 600 mg daily or more without showing signs of drug intoxication, while others become intoxicated with 200 mg or less. On occasion, a patient who has been stabilized for months or years on a constant dose of the drug suddenly develops nystagmus and ataxia. In some patients who are being started on phenytoin therapy, the serum concentration of the drug often remains low despite gradually increasing doses, until suddenly a point is reached when it rises dangerously close to the toxic range with a further increment.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Atkinson, A. J., Shaw, J. M.: Pharmacokinetic study of a patient with diphenylhydantoin toxicity. Clin. Pharmacol. Ther. 14, 521 (1973).

    PubMed  Google Scholar 

  • Frantzen, E., Hansen, J. M., Hansen, O. E., Kristensen, M.: Phenytoin (Dilantin®) intoxication. Acta neurol. scand. 43, 440 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Gerber, N., Wagner, J. F.: Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Midiaelis-Menten equation. Res. Comm. Chem. Path. Pharmac. 3, 455 (1972).

    CAS  Google Scholar 

  • Hansen, J. M., Siersbaek-Nielsen, K., Skovsted, L.: Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man. Clin. Pharmacol. Ther. 12, 539 (1971).

    PubMed  CAS  Google Scholar 

  • Houghton, G. W., Richens, A.: Rate of elimination of tracer doses of phenytoin at different steady-state serum concentrations in epileptic patients. Brit. J. clin. Pharmac. 1, 155 (1974 a).

    CAS  Google Scholar 

  • Houghton, G. W., Richens, A.: Inhibition of phenytoin metabolism by sulthiame in epileptic patients. Brit. J. clin. Pharmac. 1, 59 (1974 b).

    CAS  Google Scholar 

  • Houghton, G. W., Richens, A.: Phenytoin intoxication induced by sulthiame in epileptic patients. J. Neurol. Neurosurg. Psychiat. 37, 275 (1974 c).

    Article  PubMed  CAS  Google Scholar 

  • Houghton, G. W., Richens, A.: Phenytoin intoxication induced by sulthiame — a common clinical problem. In: Epilepsy Proceedings of Hans Berger Centenary Symposium, Edinburgh. Churchill Livingstone (1974 d).

    Google Scholar 

  • Kutt, H., McDowell, F.: Management of epilepsy with diphenylhydantoin sodium. J. Amer. med. Ass. 203, 969 (1968).

    Article  CAS  Google Scholar 

  • Kutt, H.: Diphenylhydantoin. Interactions with other drugs in man. In: Antiepileptic Drugs (Eds. D. M. Woodbury, J. K. Penry, R. P. Schmidt), p. 169. New York: Raven Press 1972.

    Google Scholar 

  • Mawer, G. E., Mullen, P. W., Rodgers, M., Robins, A. J., Lucas, S. B.: Phenytoin dose adjustment in epileptic patients. Brit. J. clin. Pharmac. 1, 163 (1974).

    CAS  Google Scholar 

  • Richens, A.: Drug estimation in the treatment of epilepsy. Proc. roy. Soc. Med. 67, 1227 (1974).

    CAS  Google Scholar 

  • Richens, A.: Results of a phenytoin quality control scheme. In: Clinical Pharmacology of Anti-Epileptic Drugs (Eds. H. Schneider, D. Janz, C. Gardner-Thorpe, H. Meinardi, A. L. Sherwin), p. 293. Berlin-Heidelberg-New York: Springer 1975.

    Google Scholar 

  • Richens, A., Houghton, G. W.: Phenytoin intoxication caused by sulthiame. Lancet 1973 II, 1442.

    Article  Google Scholar 

  • Vajda, F. J. E., Prineas, R. J., Lovell, R. R. H.: Interaction between phenytoin and the benzodiazepines. Brit. med. J. 1971 1, 346.

    Article  PubMed  CAS  Google Scholar 

  • Vessell, E. S., Passananti, G. T., Greene, F. E.: Impairment of drug metabolism in man by allopurinol and nortriptyline. New Engl. J. Med. 283, 1484 (1970).

    Google Scholar 

  • Wallace, J.: Simultaneous spectrophotometric determination of diphenylhydantoin and phenobarbital in biologic specimens. Clin. Chem. 15, 323 (1969).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1975 Springer-Verlag Berlin-Heidelberg

About this paper

Cite this paper

Richens, A., Houghton, G.W. (1975). Effect of Drug Therapy on the Metabolism of Phenytoin. In: Schneider, H., Janz, D., Gardner-Thorpe, C., Meinardi, H., Sherwin, A.L. (eds) Clinical Pharmacology of Anti-Epileptic Drugs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85921-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85921-2_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-85923-6

  • Online ISBN: 978-3-642-85921-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics